Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
Reduction of SSTRs and DRD2 Expression in Resistant Tumors Generally, a reduced expression of functional DA and SS receptors in pituitary tumors has been associated with a poor response
PTD-DBM & GHK-Cu Peptides in Revolutionising Hair Growth Discuss how PTD-DBM and GHK-Cu peptides in promote hair regrowth
Diarrhea is expected during dose escalation and resolves for most users
Cell Commun Signal 24 , 149 (2026)
This blue copper peptide can effectively promote the production of collagen and elastin proteins, increase vascular growth and antioxidant capacity, and stimulate the production of glucose polyamines (GAGs), helping the skin restore its innate ability for self repair